NEW YORK (GenomeWeb News) – 23andMe today said that it has closed on its Series C financing, raising more than $22 million.
New investor Johnson & Johnson Development Corp. participated in the round, which also included New Enterprise Associates and Google Ventures, the Mountain View, Calif.-based personal genetics testing firm said in a statement.